Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029029 · ClinicalTrials.gov registry record · Phase 2
Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00029029: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00029029 is a Phase 2 study that has completed, run by Mayo Clinic. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029029, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells and may help to relieve pain caused by bone metastases. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in relieving pain in patients who have bone metastases.
Interventions
- PROCEDURE pain therapy
- PROCEDURE radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10-13 |
| Est. Completion | 2002-10-24 |
| Phase | Phase 2 |
What the finished NCT00029029 record still lists
NCT00029029 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which pain therapy is the first listed.
NCT00029029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029029 about?
NCT00029029 is a clinical study titled "Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases". RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells and may help to relieve pain caused by bone metastases. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in relieving pain in patients who have bone metastases.
What is the current status of trial NCT00029029?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-10-13. Estimated completion is 2002-10-24.
What interventions are being tested in trial NCT00029029?
The interventions under investigation include: pain therapy (PROCEDURE), radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00029029?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI